ASND vs SMMT: stock comparison and AI forecast
Ascendis Pharma A/S (ASND) and Summit Therapeutics Inc. (SMMT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ASND Ascendis Pharma A/S
- Price
- $256.82 +4.3% · 6M
- Market Cap
- $16.86B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
SMMT Summit Therapeutics Inc.
- Price
- $16.33 -4.8% · 6M
- Market Cap
- $13.03B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ASND is 1.3 times larger than SMMT by market capitalization ($16.86B against $13.03B).
- Over the last six months ASND returned +4.3% and SMMT -4.8%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ASND | SMMT |
|---|---|---|
| Market Cap | $16.86B | $13.03B |
| P/B Ratio | – | 23.07x |
| EPS | $-15.40 | $-1.39 |
| Book Value/Share | – | $0.71 |
| Revenue/Share | $20.59 | – |
| FCF/Share | $-0.10 | $-0.66 |
Profitability & Margins
| Metric | ASND | SMMT |
|---|---|---|
| ROE | – | -147.5% |
| ROA | – | -120.2% |
| ROIC | -121.1% | – |
| Gross Margin | 86.1% | – |
| Operating Margin | -23.7% | – |
| EBT Margin | -33.4% | – |
| Tax Rate | -6.0% | – |
Financial Health
| Metric | ASND | SMMT |
|---|---|---|
| Current Ratio | 1.04x | 5.99x |
| Quick Ratio | 0.76x | – |
| D/E Ratio | – | 0.23x |
| Financial Leverage | – | 1.23x |
| Interest Coverage | – | -508.6x |
| Working Capital | $47M | $550M |
Cash Flow
| Metric | ASND | SMMT |
|---|---|---|
| Operating Cash Flow | -$2M | -$525M |
| Free Cash Flow | -$7M | -$527M |
| Capital Spending | -$5M | -$2M |
| FCF/Sales | -0.5% | – |
| CapEx/Sales | 0.3% | – |
Operational Efficiency
| Metric | ASND | SMMT |
|---|---|---|
| Asset Turnover | 0.92x | – |
| Inventory Turnover | 0.6x | – |
| Fixed Assets Turnover | 8.1x | – |
| Days Inventory | 662 days | – |
Income Statement
| Metric | ASND | SMMT |
|---|---|---|
| Total Revenue | $1.35B | – |
| Operating Income | -$320M | – |
| Net Income | – | -$833M |
| R&D Expense | $599M | $607M |
| SG&A Expense | $884M | – |
| Cost of Goods Sold | $188M | – |
Dividend & Shareholder Information
| Metric | ASND | SMMT |
|---|---|---|
| Shares Outstanding | 66M | 798M |
ASND vs SMMT: stock comparison and AI forecast
Which is bigger, ASND or SMMT?
ASND is 1.3 times larger than SMMT by market capitalization ($16.86B against $13.03B).
Which stock performed better over the last six months, ASND or SMMT?
Over the last six months ASND returned +4.3% and SMMT -4.8%.
Which one does Intratio's AI model rank higher, ASND or SMMT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.